|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
52255423
線上人數 :
1006
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 738961-738970 / 2348487 (共234849頁)
<< < 73892 73893 73894 73895 73896 73897 73898 73899 73900 73901 > >>
每頁顯示[10|25|50]項目
| 國立政治大學 |
2005 |
RosettaNet標準使用現況調查
|
鄭天澤 |
| 臺大學術典藏 |
2018-09-10T03:41:20Z |
Rosiglitazone (BRL 49653) Enhances Insulin Secretory Response via Phosphatidylinositol 3-Kinase Pathway
|
Yang, C. and Chang, T.-J. and Chang, J.-C. and Liu, M.-W. and Tai, T.-Y. and Hsu, W.H. and Chuang, L.-M.; TIEN-JYUN CHANG |
| 國立臺灣大學 |
2001 |
Rosiglitazone (Brl 49653) Enhances Insulin Secretory Response Via Phosphatidylinositol 3-Kinase Pathway
|
戴東原; 莊立民; TAI, TONG-YUAN; CHUANG, LEE-MING |
| 臺大學術典藏 |
2020-05-25T02:46:18Z |
Rosiglitazone (BRL 49653) Enhances Insulin Secretory Response via Phosphatidylinositol 3-Kinase Pathway
|
Yang C.;Tien-Jyun Chang;Chang J.-C.;Liu M.-W.;Tai T.-Y.;Hsu W.H.;Chuang L.-M.; Yang C.; TIEN-JYUN CHANG; Chang J.-C.; Liu M.-W.; Tai T.-Y.; Hsu W.H.; Chuang L.-M. |
| 中國文化大學 |
2016-04 |
Rosiglitazone activation of PPAR gamma-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced mitochondrial dysfunction and oxidative stress
|
Chiang, MC (Chiang, Ming-Chang); Nicol, CJ (Nicol, Christopher J.); Cheng, YC (Cheng, Yi-Chuan); Lin, KH (Lin, Kuan-Hung); Yen, CH (Yen, Chia-Hui); Lin, CH (Lin, Chien-Hung) |
| 中國文化大學 |
2015-11 |
Rosiglitazone activation of PPAR gamma-dependent signaling is neuroprotective in mutant huntingtin expressing cells
|
Chiang, Ming-Chang; Cheng, Yi-Chuan; Nicol, Christopher J.; Lin, Kuan-Hung; Yen, Chia-Hui; Chen, Shiang-Jiuun; Huang, Rong-Nan |
| 臺大學術典藏 |
2020-02-03T08:43:46Z |
Rosiglitazone activation of PPAR�^-dependent signaling is neuroprotective in mutant huntingtin expressing cells
|
Chiang M.-C.; Cheng Y.-C.; Nicol C.J.; Lin K.-H.; Yen C.-H.; Chen S.-J.; Huang R.-N.; RONG-NAN HUANG |
| 臺大學術典藏 |
2015 |
Rosiglitazone activation of PPAR�^-dependent signaling is neuroprotective in mutant huntingtin expressing cells
|
Chiang M.-C.;Cheng Y.-C.;Nicol C.J.;Lin K.-H.;Yen C.-H.;Chen S.-J.;Huang R.-N.; Chiang M.-C.; Cheng Y.-C.; Nicol C.J.; Lin K.-H.; Yen C.-H.; Chen S.-J.; Huang R.-N.; SHIANG-JIUUN CHEN |
| 國家衛生研究院 |
2009-07 |
Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins
|
Wu, JS;Lin, TN;Wu, KK |
| 國家衛生研究院 |
2023-05-01 |
Rosiglitazone does not affect the risk of inflammatory bowel disease: A retrospective cohort study in Taiwanese type 2 diabetes patients
|
Tseng, CH |
顯示項目 738961-738970 / 2348487 (共234849頁)
<< < 73892 73893 73894 73895 73896 73897 73898 73899 73900 73901 > >>
每頁顯示[10|25|50]項目
|
